ESTRELLA IMMUNOPHARMA, INC. Stock Redeemed or Called During Period, Shares
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Stock Redeemed or Called During Period, Shares of 467.12 thousand shares for the 6-month period ending 2024-12-31, per its 10-KT filed 2025-03-25.
Financial Statements › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodShares · last filed 2025-03-25
- ESTRELLA IMMUNOPHARMA, INC. stock redeemed or called during period, shares for the quarter ending 2024-12-31 was 0.00 shares.
- ESTRELLA IMMUNOPHARMA, INC. stock redeemed or called during period, shares for the quarter ending 2024-09-30 was 467.12K shares.
- ESTRELLA IMMUNOPHARMA, INC. stock redeemed or called during period, shares for fiscal 2024 was 467.12K shares.
| Period end | Stock Redeemed or Called During Period, Shares | Stock Redeemed or Called During Period, Shares 3 month | Stock Redeemed or Called During Period, Shares 6 month | Stock Redeemed or Called During Period, Shares 12 month |
|---|---|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-KT 6 month − 10-Q 3 month · filed 2025-03-25 | 467.12K shares 10-KT · filed 2025-03-25 | ||
| 2024-09-30 | 467.12K shares 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | 467.12K shares 10-K · filed 2024-09-27 | |||
| 2023-09-29 | 467.12K shares 10-KT · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |